Dopaminergic blocking effects of antipsychotic drugs.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology; D018492:Dopamine Antagonists; D006220:Haloperidol / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism; D010640:Phenothiazines; D051381:Rats; D011955:Receptors, Drug; D013378:Substantia Nigra / Q000187:drug effects; D013681:Tegmentum Mesencephali / Q000187:drug effects
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D010640:Phenothiazines; D011955:Receptors, Drug; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine